Article

Article detail, metadata, authors, and available full-text links.

Paper reader

Loading paper...

article · 2018

Ocrelizumab May Reduce Tissue Damage in Chronic Active Lesions as Measured by Change in T1 Hypo-Intensity of Slowly Evolving Lesions in Patients With Primary Progressive Multiple Sclerosis (P3.376)

To assess the effect of ocrelizumab compared to placebo on T1 hypo-intense volume and mean T1-intensity of slowly evolving lesions (SELs) in patients with pr...

1 citationsDOI: https://doi.org/10.1212/wnl.90.15_supplement.p3.376
Ocrelizumab May Reduce Tissue Damage in Chronic Active Lesions as Measured by Change in T1 Hypo-Intensity of Slowly Evolving Lesions in Patients With Primary Progressive Multiple Sclerosis (P3.376)